In This Section:
Obesity
Obesity
The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.
Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
This educational hub has been supported by Boehringer Ingelheim. Boehringer Ingelheim has had no influence over the content. This educational hub is not intended for UK or IRELAND based physicians.
Close X
Other videos you might like
Watch time: 7m 3s
Watch time: 7m 20s
Video
AHA 23 Late-Breaker Discussion: The SELECT Trial
Watch time: 21m 35s
Video
CardioNerds @AHA23: Presidential Advisory on CKM Health
Watch time: 14m 32s
Video
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial
Watch time: 13m 24s
Video
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Watch time: 13m 28s
Video
ECO 23: Impact of Obesity on Heart Failure Outcomes
Watch time: 7m 7s
Video Series
e-SPACE Cardio-Renal-Metabolic 2023
Watch time: 16h 19m 46s (19 videos)
Video
Obesity Management Strategies in 2023
Watch time: 17m 7s
Broadcast
e-SPACE CRM 2023 – Day Two
Broadcast
e-SPACE CRM 2023 – Day One
Video Series
Dysphagia and the Management of Patients in Need of Lipid-Lowering
Watch time: 1h 7m 2s (4 videos)
Recent Videos
Watch time: 7m 3s
Video
CardioNerds @AHA23: The SELECT Trial
Watch time: 11m 47s
Watch time: 7m 20s
Video
AHA 23 Late-Breaker Discussion: The SELECT Trial
Watch time: 21m 35s
Video
CardioNerds @AHA23: Presidential Advisory on CKM Health
Watch time: 14m 32s
Video
EASD 23: Efinopegdutide in NAFLD & T2D patients
Watch time: 6m 18s